Synlogic

Synlogic needed to develop marketing collateral and digital advertising to recruit for a Phase 3 clinical trial of their investigational medicine to reduce phenylalanine in adult patients with phenylketonuria (PKU).

With an extremely tight production schedule they called on us to deliver patients and a new brand on time and with a brand new visual identity to distinguish themselves in the marketplace.